Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study.
作者信息
Martin-Rendon Enca, Gyöngyösi Mariann
机构信息
Nuffield Division of Clinical Laboratory Sciences, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Department of Cardiology, Medical University of Vienna, Vienna, Austria.
出版信息
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S69-S72. doi: 10.21037/cdt.2016.11.13.
Abstract
摘要
相似文献
1
Mesenchymal stromal cell therapy as treatment for ischemic heart failure: the MSC-HF study.间充质基质细胞疗法治疗缺血性心力衰竭：MSC-HF研究
Cardiovasc Diagn Ther. 2017 Jun;7(Suppl 2):S69-S72. doi: 10.21037/cdt.2016.11.13.
2
Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial).首例随机、双盲、安慰剂对照的自体骨髓间充质干细胞心肌内注射治疗慢性缺血性心力衰竭的研究（MSC-HF 试验）的原理和设计。
Am Heart J. 2012 Sep;164(3):285-91. doi: 10.1016/j.ahj.2012.05.026.
3
Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia.间充质基质细胞衍生的细胞外囊泡在缺氧缺血后保护胎儿大脑。
Stem Cells Transl Med. 2016 Jun;5(6):754-63. doi: 10.5966/sctm.2015-0197. Epub 2016 May 9.
4
Therapeutic potentials of umbilical cord-derived mesenchymal stromal cells for ischemic-type biliary lesions following liver transplantation.脐带间充质基质细胞对肝移植后缺血型胆管病变的治疗潜力
Cytotherapy. 2017 Feb;19(2):194-199. doi: 10.1016/j.jcyt.2016.11.005. Epub 2016 Dec 8.
5
Functional characterization of human umbilical cord-derived mesenchymal stem cells for treatment of systolic heart failure.人脐带间充质干细胞治疗收缩性心力衰竭的功能特性研究
Exp Ther Med. 2016 Nov;12(5):3328-3332. doi: 10.3892/etm.2016.3748. Epub 2016 Sep 26.
6
Synthetic extracellular matrix mimic hydrogel improves efficacy of mesenchymal stromal cell therapy for ischemic cardiomyopathy.合成细胞外基质模拟水凝胶提高间充质基质细胞治疗缺血性心肌病的疗效。
Acta Biomater. 2018 Apr 1;70:71-83. doi: 10.1016/j.actbio.2018.01.005. Epub 2018 Jan 16.
7
Pathological role of angiostatin in heart failure: an endogenous inhibitor of mesenchymal stem-cell activation.血管抑素在心力衰竭中的病理作用：间充质干细胞激活的内源性抑制剂
Heart. 2009 Feb;95(4):283-9. doi: 10.1136/hrt.2008.152223. Epub 2008 Dec 18.
8
Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.同种异体间充质干细胞通过刺激内皮祖细胞恢复心力衰竭中的内皮功能。
EBioMedicine. 2015 Mar 28;2(5):467-75. doi: 10.1016/j.ebiom.2015.03.020. eCollection 2015 May.
9
[Role of mesenchymal stem cells in angiogenesis and clinical applications].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Aug;18(4):1084-7.
10
In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing.人毛囊真皮鞘间充质基质细胞的体外特性及其在促进糖尿病伤口愈合中的潜力。
Cytotherapy. 2015 Aug;17(8):1036-51. doi: 10.1016/j.jcyt.2015.04.001. Epub 2015 May 13.
引用本文的文献
1
Influence of Waist-to-Hip Ratio on the Prognosis of Heart Failure Patients With Revascularized Coronary Heart Disease.腰臀比对冠状动脉血运重建术后心力衰竭患者预后的影响。
Front Cardiovasc Med. 2021 Oct 1;8:732200. doi: 10.3389/fcvm.2021.732200. eCollection 2021.
2
CellSaic, A Cell Aggregate-Like Technology Using Recombinant Peptide Pieces for MSC Transplantation.CellSaic，一种使用重组肽片段进行间充质干细胞移植的类细胞聚集体技术。
Curr Stem Cell Res Ther. 2019;14(1):52-56. doi: 10.2174/1574888X13666180912125157.
本文引用的文献
1
Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews.心脏病的细胞治疗：两项Cochrane系统评价的试验序贯分析
Clin Pharmacol Ther. 2016 Jul;100(1):88-101. doi: 10.1002/cpt.344. Epub 2016 May 9.
2
Stem cell treatment for acute myocardial infarction.急性心肌梗死的干细胞治疗
Cochrane Database Syst Rev. 2015 Sep 30;2015(9):CD006536. doi: 10.1002/14651858.CD006536.pub4.
3
Adult Bone Marrow Cell Therapy for Ischemic Heart Disease: Evidence and Insights From Randomized Controlled Trials.成人骨髓细胞疗法治疗缺血性心脏病：来自随机对照试验的证据与见解
Circ Res. 2015 Aug 28;117(6):558-75. doi: 10.1161/CIRCRESAHA.114.304792. Epub 2015 Jul 9.
4
Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial).骨髓间充质基质细胞治疗严重缺血性心力衰竭患者：一项随机安慰剂对照试验（MSC-HF 试验）。
Eur Heart J. 2015 Jul 14;36(27):1744-53. doi: 10.1093/eurheartj/ehv136. Epub 2015 Apr 29.
5
Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data.基于个体患者数据的急性心肌梗死患者细胞心肌研究的荟萃分析（ACCRUE）
Circ Res. 2015 Apr 10;116(8):1346-60. doi: 10.1161/CIRCRESAHA.116.304346. Epub 2015 Feb 19.
6
Meta-analysis of cell therapy trials for patients with heart failure.细胞疗法治疗心力衰竭患者的荟萃分析。
Circ Res. 2015 Apr 10;116(8):1361-77. doi: 10.1161/CIRCRESAHA.116.304386. Epub 2015 Jan 28.
7
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.《2014年心脏病和中风统计数据更新：美国心脏协会报告》
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
8
Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial.经心内膜心肌间质干细胞和单核骨髓细胞治疗缺血性心肌病：TAC-HFT 随机试验。
JAMA. 2014 Jan 1;311(1):62-73. doi: 10.1001/jama.2013.282909.
9
Spindle shaped human mesenchymal stem/stromal cells from amniotic fluid promote neovascularization.羊水来源的梭形人间质干细胞/基质细胞促进血管新生。
PLoS One. 2013;8(1):e54747. doi: 10.1371/journal.pone.0054747. Epub 2013 Jan 24.
10
Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial.经心内膜注射异体与自体骨髓间充质干细胞治疗缺血性心肌病的比较：POSEIDON 随机试验。
JAMA. 2012 Dec 12;308(22):2369-79. doi: 10.1001/jama.2012.25321.
Zotero 插件